NRXP icon

NRX Pharmaceuticals
NRXP

Overview Fund Activity

30 hedge funds and large institutions have $2.07M invested in NRX Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 10 increasing their positions, 6 reducing their positions, and 4 closing their positions.

Holders
30
Holders Change
-3
Holders Change %
-9.09%
% of All Funds
0.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
10
Reduced
6
Closed
4
Calls
$109K
Puts
$13K
Net Calls
+$96K
Net Calls Change
-$211K

Top Buyers

1
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$53.1K
2
BCM
2
Bridgeway Capital Management
Texas
$152K
3
VF
3
Virtu Financial
New York
$30K
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$974K
5
UBS Group
5
UBS Group
Switzerland
$12.3K

Top Sellers

1
AWM
1
AE Wealth Management
Kansas
$0
2
ETC
2
Exchange Traded Concepts
Oklahoma
$0
3
HF
3
HRT Financial
New York
$0
4
HSA
4
HBK Sorce Advisory
Pennsylvania
$19.3K
5
Group One Trading
5
Group One Trading
Illinois
$14.1K
Name Holding Trade Value Shares
Change 		Shares
Change %
LFG
26
Larson Financial Group
Missouri
$144 – – –
CCA
27
Column Capital Advisors
Indiana
$66 – – –
AWM
28
AE Wealth Management
Kansas
– -$32.8K -2,952 Closed
ETC
29
Exchange Traded Concepts
Oklahoma
– -$29.9K -2,692 Closed
HF
30
HRT Financial
New York
– -$29K -2,650 Closed
TSS
31
Two Sigma Securities
New York
– -$11.6K -1,045 Closed
1
2